612 related articles for article (PubMed ID: 26233567)
1. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds.
Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive detection of lung cancer using exhaled breath.
Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M
Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867
[TBL] [Abstract][Full Text] [Related]
6. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
8. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
9. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
10. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
11. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
12. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
13. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
14. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
15. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
16. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
17. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
18. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
19. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
20. Breath gas aldehydes as biomarkers of lung cancer.
Fuchs P; Loeseken C; Schubert JK; Miekisch W
Int J Cancer; 2010 Jun; 126(11):2663-70. PubMed ID: 19839051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
